REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/17/2025
Back to search
Official data from USPTO
ENERZAIR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
03/17/2025
Trademark type
Combined
Nice classes
5
Filing date
04/16/2019
Registration date
03/17/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/17/2020
Last transaction
03/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
25
Owner location
CH
Examiner
ORTIGA PALMER, RAMONA
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "ENERZAIR" in green preceded by a design resembling an upside-down diamond comprising two segments where the bottom segment comprises three connected triangles in varying shades of yellow and where the top segment's left half comprises two connected triangles in varying shades of green and the right half comprises two connected triangles in varying shades of blue.
Holders and representatives
Holders
NOVARTIS AG
Representatives
Maury M. Tepper, III Tepper & Eyster, PLLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publications
History of USPTO decisions and trademark events.
28 publications found
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
08/07/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/23/2020
FIMP
FINAL DISPOSITION PROCESSED
07/23/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/17/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/31/2019
PUBO
PUBLISHED FOR OPPOSITION
12/31/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/18/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/18/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/11/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/23/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/30/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/29/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/29/2019
RFNT
REFUSAL PROCESSED BY IB
09/06/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/22/2019
RFRR
REFUSAL PROCESSED BY MPU
08/22/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
07/29/2019
CNRT
NON-FINAL ACTION WRITTEN
07/28/2019
MAFR
APPLICATION FILING RECEIPT MAILED
07/23/2019
DOCK
ASSIGNED TO EXAMINER
07/18/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/18/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/08/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/27/2019
Continuous trademark protection
Get notified about every new filing that threatens ENERZAIR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.